Pain Management

Chronic pain, multimodal strategies, interventional options, and safety concerns.

  • 2 Tracked terms
  • Last 30 days Feed window

What this topic collects on

An article joins this feed when it matches these terms. Each one is also a search of its own.

Latest in Pain Management


newsroom.uw.edu > blog > how-can-the-mind-be-harnessed-to-ease-pain

How can the mind be harnessed to ease pain?

20+ min ago   (485+ words) Seattle-area older adults with chronic pain are being sought for a University of Washington School of Medicine study evaluating mind-body treatments for pain management. “As we age, we have more aches and pains for all kinds of reasons, including arthritis,…...


star-telegram.com-telegram.com

Compression boots vs. compression socks: How they differ and which one is right for you

50+ min ago   (545+ words) If your For You page has served up a wellness influencer zipping into a pair of inflatable leg sleeves before her morning matcha, you have met compression boots. The clinical-looking recovery gear that once lived in hospitals and elite training…...


medium.com > frequency-change > some-aches-dont-want-to-be-soothed-faade9b63b94

Some Aches Don’t Want to Be Soothed

21+ hour, 28+ min ago   (22+ words) On grief, distance, migraines, cultural longing, teenage audacity, and why a stranger calling me “dear” can feel like one intimacy too far....


pharmabiz.com > NewsDetails.aspx

Adneuris Therapeutics presents novel data on lead candidate, cebranopadol to treat moderate-to-severe acute pain at PAINWeek 2026

3+ day, 5+ hour ago   (249+ words) Monmouth Junction, New Jersey Saturday, Septembe... Adneuris Therapeutics presents novel data on lead candidate, cebranopadol to treat moderate-to-severe acute pain at PAINWeek 2026 Adneuris Therapeutics, a wholly owned subsidiary of Tris Pharma advancing a new kind of pain medicine, announced novel…...


seattleschild.com > feet-grow-during-pregnancy

Foot pain during pregnancy? Why your feet hurt — and what helps

4+ day, 18+ min ago   (813+ words) Yes, your feet do grow in pregnancy and that's good reason to get new shoes (iStock) Updated September 10, 2026 “That’s not even possible,” my husband said. Not something a new father should say to their largely pregnant partner. We were talking…...


news.harvard.edu > gazette > story > 2026 > 09 > who-needs-opioids

Who needs opioids? — Harvard Gazette

4+ day, 4+ hour ago   (774+ words) For a patient having their wisdom teeth removed, the days after surgery can bring an important question: How much pain medication will I actually need? Over-the-counter medications such as acetaminophen and ibuprofen provide adequate pain relief for most, but some…...


openpr.com > news > 4627274 > global-trends-overview-the-rapid-evolution-of-the-non-opioid

Global Trends Overview: The Rapid Evolution of the Non-Opioid Pain Treatment Market

4+ day, 14+ hour ago   (59+ words) openPR.com Global Trends Overview: The Rapid Evolution of the Non-Opioid Pain Treatment Market Press release from: The Business research company Permanent link to this press release: You can edit or delete your press release Global Trends Overview: The Rapid…...


foodanddrinktechnology.com > news > 69899 > britains-pain-crisis-downplayed

Britain's pain crisis downplayed

4+ day, 8+ hour ago   (398+ words) New research from functional nutrition brand The Turmeric Co. suggests the UK is quietly living with far more physical pain than it lets on — and routinely hiding it from the people around it. The brand’s State of the Nation report,…...


markets.businessinsider.com > news > stocks > adneuris-therapeutics-presents-novel-data-on-lead-candidate-cebranopadol-for-the-treatment-of-moderate-to-severe-acute-pain-at-painweek-2026-1036536586

Adneuris Therapeutics Presents Novel Data on Lead Candidate, Cebranopadol for the Treatment of Moderate-to-Severe Acute Pain at PAINWeek 2026

4+ day, 7+ hour ago   (261+ words) Adneuris unveiled new abuse potential data demonstrating that cebranopadol's abuse potential may be lower than that of Schedule II and Schedule IV pain drugs, further differentiating its dual NOP/MOP mechanism from drugs like oxycodone. The Phase 3 ALLEVIATE studies met…...